Pharmafile Logo

CoreLab Partners

With over 36 years of global experience, CoreLab Partners provides its clinical trial sponsors best-in-class centralized cardiac safety & efficacy services and independent medical image assessment solutions; all designed to facilitate successful new drug development in the pharmaceutical, biotechnology and medical device market sectors.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Genesis Research Group

Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

View Profile

Company Details

Elisabethstrasse 91, 80797 Munich, Germany
+49 89 2024 4497 0

 Latest Content from PMHub 

Modern alternatives to banner exhibition stands (why a reusable pharma exhibition stand could save you money)

When it comes to exhibiting, banner stands are undoubtedly cost-effective. And, if you are struggling with your budget, we supply a range of good quality banner stands in various sizes....

Lucid Group gets into the Bake Off Spirit

Lucid SPIRIT, Lucid’s charity working group, organised a spellbinding bake off to raise money for its charity partner, Wycombe Homeless Connection (WHC).Yesterday employees across the business enjoyed home-baked delights as...

Is our health at risk by delaying Dr appointments?

It’s Cervical Screening Awareness week 10-16 June, so now is the perfect time to check when your last appointment was.

Wanda Lesowiec did it. Could you?

How a background in pharma can mean a bright future in medical communications

Apex launches new immersive gastronomic event experience in the pharma sector

Specialist pharmaceutical conference and event management company Apex has launched the ultimate immersive gastronomic experience in the UK and global events market.

Precision medicine from concept to clinic

In our latest edition of ‘Perspective’ magazine, we examine the challenges and opportunities for several stakeholders impacted by the dawn of precision medicine